Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Topotecan + Gemcitabine in Platinum-resistant Ovarian Cancer
NCT00429559Phase 2Completed
- Sponsor
- Hellenic Oncology Research Group
- Start
- Jun 2006
- Primary completion
- Jul 2011
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 2 trial of topotecan liposome, gemcitabine in ovarian cancer, sponsored by Hellenic Oncology Research Group. Started Jun 2006; status: completed.
02
Drugs
topotecan liposomegemcitabine
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT00429559.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00429559.